Nervgen Pharma NGEN
NASDAQ NGEN
$1.52 -0.02 (-1.30%)
As of: Oct 21, 2026 · 2:44 PM EDT

Nervgen Pharma (NGEN) Receivables - Other (2024 - 2025)

Updated

Analysis

Nervgen Pharma (NGEN) Receivables - Other (2024 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.92 Bn 1,105.50 Bn 19.71 Bn
2 Johnson & Johnson 617.57 Bn 536.10 Bn 17.26 Bn
3 AbbVie 501.37 Bn 474.48 Bn 12.70 Bn
4 Merck 367.96 Bn 322.33 Bn 12.21 Bn
5 Novartis Ag 297.98 Bn 261.97 Bn 11.24 Bn
6 Astrazeneca 261.45 Bn 235.14 Bn 12.86 Bn
7 Amgen 236.30 Bn 191.70 Bn 7.24 Bn
8 Gilead Sciences 190.27 Bn 164.46 Bn 6.22 Bn
9 Pfizer 169.65 Bn 116.29 Bn 10.94 Bn
10 Nervgen Pharma 109.94 Mn 8.82 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 6,111.12
Dec 31, 2024 5,832.14
API Access

Nervgen Pharma Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=NGEN&period=max&api_key=YOUR_API_KEY